MedMira Reports 2017 First Quarter Financial Results

MedMira Reports 2017 First Quarter Financial Results

ID: 515321

(firmenpresse) - HALIFAX, NOVA SCOTIA -- (Marketwired) -- 12/30/16 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), reported today on its financial results for the three month period ending October 31, 2016. Revenues decreased in the first quarter of FY2017 compared to the first quarter of FY2016 due to the conclusion of a development contract which had generated significant service sales for the Company.

Q1 FY2017 Financial Highlights

About MedMira

MedMira is the developer and owner of Rapid Vertical Flow (RVF) Technologya. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad™ brands in global markets. MedMira's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada and the Company has a sales and customer service office located in Atlanta, Georgia, United States. For more information visit . Follow us on and .

This news release contains forward-looking statements, which involve risk and uncertainties and reflect the Company's current expectation regarding future events including statements regarding possible approval and launch of new products, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.





Contacts:
MedMira Inc.
Andrea Young
Corporate Communications
902-450-1588

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Global Abdominal Surgical Robot Market Poised to Attain Substantial Growth through 2022 Global Gastrointestinal Endoscopy Market grow at a CAGR of 5.09% and worth 35.36 Billion USD by 2021
Bereitgestellt von Benutzer: Marketwired
Datum: 31.12.2016 - 01:00 Uhr
Sprache: Deutsch
News-ID 515321
Anzahl Zeichen: 0

contact information:
Town:

HALIFAX, NOVA SCOTIA



Kategorie:

Medical Devices



Diese Pressemitteilung wurde bisher 474 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MedMira Reports 2017 First Quarter Financial Results"
steht unter der journalistisch-redaktionellen Verantwortung von

MedMira Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

MedMira Reports FY2017 Second Quarter Results ...

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/31/17 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), reported today on its financial results for the three and six month periods ending January 31, 2017. The Company recorded steady product sales with incre ...

MedMira Unaware of Any Material Change ...

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/09/17 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), at the request of IIROC, wishes to confirm that the Company's management is unaware of any material change in the Company's operations that wou ...

Alle Meldungen von MedMira Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z